Barclays PLC Novavax Inc Put Options Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$3.76 - $6.02 $1.09 Million - $1.75 Million	-290,000 Reduced 74.36%	100,000 $478,000
Q4 2023 Feb 15, 2024	BUY	$4.8 - $7.67 $1.87 Million - $2.99 Million	390,000 New	390,000 $1.87 Million
Q1 2023 May 04, 2023	SELL	$5.76 - $12.48 $12,096 - $26,208	-2,100 Reduced 22.11%	7,400 $52,000
Q4 2022 Feb 13, 2023	BUY	$8.86 - $25.04 $84,170 - $237,880	9,500 New	9,500 $98,000
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $6.35 Million - $13.2 Million	174,900 New	174,900 $9 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.